Bank of The West decreased its stake in Monsanto Company (NYSE:MON) by 15.7% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 32,245 shares of the basic materials company’s stock after selling 6,013 shares during the period. Bank of The West’s holdings in Monsanto were worth $3,816,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in MON. Town & Country Bank & Trust CO dba First Bankers Trust CO raised its position in shares of Monsanto by 10.7% in the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 6,956 shares of the basic materials company’s stock valued at $787,000 after buying an additional 675 shares during the period. Prospera Financial Services Inc raised its position in shares of Monsanto by 90.8% in the first quarter. Prospera Financial Services Inc now owns 3,754 shares of the basic materials company’s stock valued at $430,000 after buying an additional 1,786 shares during the period. Grassi Investment Management raised its position in shares of Monsanto by 0.9% in the first quarter. Grassi Investment Management now owns 47,275 shares of the basic materials company’s stock valued at $5,352,000 after buying an additional 400 shares during the period. First PREMIER Bank raised its position in shares of Monsanto by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares during the period. Finally, Bank of Montreal Can raised its position in shares of Monsanto by 17.2% in the first quarter. Bank of Montreal Can now owns 664,718 shares of the basic materials company’s stock valued at $75,246,000 after buying an additional 97,355 shares during the period. Institutional investors own 75.28% of the company’s stock.
Monsanto Company (MON) opened at 116.87 on Friday. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97. The company has a market cap of $51.34 billion, a P/E ratio of 25.24 and a beta of 1.07. The firm has a 50-day moving average price of $117.38 and a 200-day moving average price of $115.36.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. Monsanto’s revenue was up 1.0% compared to the same quarter last year. Equities research analysts anticipate that Monsanto Company will post $4.89 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.85%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s payout ratio is currently 46.75%.
COPYRIGHT VIOLATION WARNING: “Monsanto Company (MON) Shares Sold by Bank of The West” was published by BNB Daily and is owned by of BNB Daily. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/monsanto-company-mon-shares-sold-by-bank-of-the-west-updated.html.
Several brokerages have issued reports on MON. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. Barclays PLC boosted their price target on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, June 29th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 price target (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Finally, Citigroup Inc. reissued a “neutral” rating and issued a $126.00 price target (up from $125.00) on shares of Monsanto in a research note on Monday, July 10th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have assigned a buy rating to the company. Monsanto has a consensus rating of “Hold” and a consensus target price of $123.15.
In other Monsanto news, SVP Janet M. Holloway sold 7,423 shares of the business’s stock in a transaction dated Tuesday, June 13th. The stock was sold at an average price of $118.00, for a total transaction of $875,914.00. Following the completion of the sale, the senior vice president now owns 33,645 shares of the company’s stock, valued at $3,970,110. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Janet M. Holloway sold 3,337 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $118.00, for a total value of $393,766.00. Following the sale, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock valued at $8,791,281 in the last ninety days. 0.79% of the stock is currently owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.